Acoziborole
Acoziborole (SCYX-7158) is a novel benzoxaborole derivative developed as an oral treatment for human African trypanosomiasis. It demonstrates potent in vitro activity against Trypanosoma brucei, with an MIC of 0.6 μg/mL for the S427 strain, and has shown promising efficacy in advanced preclinical and clinical studies.
Product Specifications
CAS Number
1266084-51-8
Field of Research
Infectious Disease & Virology
Smiles
CC1 (C) OB (O) C2=CC (NC (=O) C3=CC=C (F) C=C3C (F) (F) F) =CC=C12
Molecular Formula
C17H14BF4NO3
Molecular Weight
367.1
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7065315 Inquire
Recombinant Staphylococcus aureus Heme A synthase (ctaA), partial
Sign In for Pricing
View Details 
C2269-07A-ML750 100 µL
CD18 (Leukocyte Function Associated Antigen, LFA-1 beta2) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
129754-ML550 100 µL
MMP2 (CLG4A, 72kD Type IV Collagenase, 72kD Gelatinase, Gelatinase A, Matrix Metalloproteinase-2, TBE-1, PEX) (MaxLight 550)
Sign In for Pricing
View Details bs-3121R-PE-Cy7 100 µL
Phospho-CRK (Tyr221) Polyclonal Antibody, PE-Cy7 Conjugated
Sign In for Pricing
View Details K0855906 1.0 µg DNA
GGTLC5P sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1)
Sign In for Pricing
View Details